~~<i id='885F8BC458'><strike id='885F8BC458'><tt id='885F8BC458'><pre id='885F8BC458'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

hotspot

author：leisure time 2025-10-02 22:56:25 - browse：79

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： SAMSHA loosens regulations on methadone treatment centers

Wikipedia

explore

leisure time

hotspot

AdoseofmethadoneKevinD.Liles/APThefederalgovernmentisunveilingnewregulationsmeanttomodernizemethadon

WSS

Biden administration opens offers in Medicare drug price negotiations

Flagship Pioneering launches a new biotech in two countries

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

New Ultima Genomics DNA sequencer can read genome for $100

Do digital therapeutics have a future in medicine?

knowledge

hotspot

Wikipedia

At least 13 dead in Texas as scorching temps continue

Rep. Raul Ruiz on the physician shortage and more

Virginia high school admissions case could be legal follow

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

In Memoriam: Notable people who died in 2023

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Walensky prepares to leave CDC — and Congress — behind

Fetal surgery at risk from Dobbs and new abortion restrictions

Trump demands the U.S. pay no more for drugs than other countries … again

Organ aging and disease risk measured by new blood test

explore

Juul spent big to court Black leaders to promote its e

SAMSHA loosens regulations on methadone treatment centers

Some dementia cases could be undiagnosed liver disease

Flagship Pioneering launches a new biotech in two countries

Mayo Clinic plans $5B tech

Vertigo drug brings hope for rare neuron disorder, Niemann

leisure time

hotspot

hotspot

hotspot